Home › Trial NCT05136898
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)
- Trial IDNCT05136898
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorUroGen Pharma Ltd.
- Enrollment8
- Start date2021-11-30
- ConditionsBladder Cancer · Urothelial Carcinoma · Urothelial Carcinoma Bladder
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.